Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine
- Registration Number
- NCT01245868
- Lead Sponsor
- Frederikssunds Hospital, Denmark
- Brief Summary
The purpose of the study is to investigate if a small amount of lignocaine added to bupivacaine for spinal anesthesia to patients planned for arthroscopic knee surgery, can shorten the duration of the sensoric and the motoric blockade.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- The patient want spinal anaesthesia
- No contradictions against spinal anaesthesia
- Healthy people (ASA-score 1 or 2)
- Body mass index < 35 and between 155 and 190 cm
Exclusion Criteria
- Known allergic reactions to planned drugs
- Neurologic disturbances
- Diabetes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lidocaine added to bupivacaine bupivacaine lidocaine is added to bupivacaine Bupivacaine bupivacaine Bupivacaine as used routinely Lidocaine added to bupivacaine Lidocaine lidocaine is added to bupivacaine
- Primary Outcome Measures
Name Time Method Duration of spinal blockade Repeating monitoring every 15 minutes after applying the blockade, up to 360 minutes.
- Secondary Outcome Measures
Name Time Method Time to fulfillment of discharge criteria from the hospital. Evaluated every 15 minutes after the operation up to 360 minutes. On average 200 to 300 minutes.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain lignocaine's effect on bupivacaine duration in spinal anesthesia?
How does lignocaine-bupivacaine combination compare to standard spinal anesthetics for knee arthroscopy?
Are there biomarkers that predict duration of spinal blockade with lignocaine-bupivacaine mixtures?
What adverse events are associated with lignocaine-adjuvant spinal anesthesia in orthopedic procedures?
How do amide local anesthetics like bupivacaine and lignocaine interact at sodium channel targets in the spinal cord?
Trial Locations
- Locations (2)
Dep. of anesthesiology, Hospital of Frederikssund
🇩🇰Frederikssund, Denmark
Jon Jacobsen
🇩🇰Frederikssund, Denmark
Dep. of anesthesiology, Hospital of Frederikssund🇩🇰Frederikssund, Denmark